• Mother and daughter cancer survior

Mother and Daughter Face Cancer Together

With busy work and family schedules, most moms and daughters welcome any opportunity to catch up over lunch. Cindy Ivin of Dyer, Ind., and Judy Trnka of Tinley Park are no different, especially when time permits.

In 2013 and early 2014, the loving pair enjoyed each other’s company at the Ingalls Infusion Center in Tinley Park, where for a period of time, both were undergoing chemotherapy treatment for cancer.

Daughter Cindy, 47, was diagnosed with an aggressive form of breast cancer the day before Thanksgiving, 2013; mom Judy, 73, found out she had non-Hodgkin’s lymphoma the year before. The effervescent wife and mother of two teen boys hosted Thanksgiving dinner the very next day without a hitch.

When Cindy finally broke the news to her family, Judy who had been bravely fighting her own battle with cancer, gave her daughter some motherly advice: Make an appointment with Dr. Kozloff.

“There was never any question which doctor Cindy would see,” Judy explained. That’s because Mark Kozloff, M.D., hematologist/oncologist and Medical Director of Ingalls Cancer Care, is not only a leading cancer expert, he’s a trusted and beloved “family member” who’s overseen Judy’s cancer care since her diagnosis in 2012.

“Their situation wasn’t easy,” Dr. Kozloff admits. “But these two ladies remained positive throughout.”

“Dr. Kozloff is a wonderful human being,” Judy adds. “Cindy and I absolutely love him and can’t say enough good things about him — and the nurses at the Infusion Center too.

The entire team is wonderful.” Following chemotherapy, Cindy underwent a double mastectomy and breast reconstruction surgery. Today, she is in remission.

Judy, who recently experienced a relapse of her cancer, has enrolled in a clinical trial at Ingalls at Dr. Kozloff’s urging. Today, she’s in remission too. Cindy and Judy remain as close as ever and have newfound admiration for the courage and grace each displayed during one of the most trying times of their lives.

“Cindy has walked through this with such strength,” Judy says, “She always remained positive and a great mom to her boys.”

“My mom really is my hero,” Cindy chimes in. “She was there for me every step of the way. We gave each other strength.”

And though neither ever wanted to face cancer, facing it together helped make each of their journeys just a little bit easier.

Ingalls First in Nation in Groundbreaking ‘Sandpiper Study’

This past spring, Ingalls became the first hospital in the nation to enroll a woman with metastatic breast cancer in the groundbreaking new Sandpiper Taselisib Clinical Study (G029058).

The national Phase III study compares the good or bad effects of the investigational drug taselisib with fulvestrant (versus placebo with fulvestrant) on women with advanced estrogen receptor-positive (ER+) breast cancer.

“Taselisib is an investigational drug in tablet form that blocks a pathway (called the PI3K pathway), which cancer cells use to grow and divide,” explains Mark Kozloff, M.D., medical director of Ingalls Cancer Care.

Dr. Kozloff enrolled the very first U.S. patient at Ingalls in May. Approximately 600 women will take part in the study nationally.

For more information about the Sandpiper Study — or more than 50 other clinical trials available at Ingalls — call 708.915.HOPE (4673).

Success Stories
  • Title

    Inspirational stories of courage and hope

Progress Magazine